MBX Biosciences, Inc.
MBX · XNASCIK 1776111fmd_1NGFKCTM7B3H4E1QGA50C2G73QManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 15 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading